The Scientist

» Politics, disease/medicine and immunology

Most Recent

image: Notable Science Quotes

Notable Science Quotes

By | June 1, 2016

14-day-old embryos, prioritizing biodiversity, and more

0 Comments

14-day-old embryos, prioritizing biodiversity, and more

0 Comments

image: Toward Targeted Therapies for Autoimmune Disorders

Toward Targeted Therapies for Autoimmune Disorders

By | June 1, 2016

14-day-old embryos, prioritizing biodiversity, and more

2 Comments

image: E.U. Delays Vote on Roundup

E.U. Delays Vote on Roundup

By | May 24, 2016

14-day-old embryos, prioritizing biodiversity, and more

4 Comments

image: FDA Approves Bladder Cancer Immunotherapy

FDA Approves Bladder Cancer Immunotherapy

By | May 23, 2016

14-day-old embryos, prioritizing biodiversity, and more

0 Comments

14-day-old embryos, prioritizing biodiversity, and more

1 Comment

image: Genetic Connections Among Human Traits

Genetic Connections Among Human Traits

By | May 16, 2016

14-day-old embryos, prioritizing biodiversity, and more

0 Comments

image: Zika Update

Zika Update

By | May 13, 2016

14-day-old embryos, prioritizing biodiversity, and more

0 Comments

image: Brazilian Science Ministry Downgraded

Brazilian Science Ministry Downgraded

By | May 12, 2016

14-day-old embryos, prioritizing biodiversity, and more

1 Comment

image: Sea Star Comeback?

Sea Star Comeback?

By | May 9, 2016

14-day-old embryos, prioritizing biodiversity, and more

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech